chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever on and off; This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (Fever on and off) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced PYREXIA (Fever on and off). At the time of the report, PYREXIA (Fever on and off) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 21-Jan-2021, Body temperature: 103 degree Fahrenheit. On 22-Jan-2021, Body temperature: 101.7 degree Fahrenheit at 12:30pm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.   Treatment for the event included acetaminophen.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Myalgia, Nausea, Pyrexia
Clinical narrative: Skin sensitivity all over body; Fever; Chills; Myalgia; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia) and HEADACHE (Headache) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia), HEADACHE (Headache) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Patient took acetaminophen and ibuprofen for treatment.
Age: 39.0
Sex: F
Vaccine: COVID19
Symptoms: Sensitive skin
Clinical narrative: Skin sensitivity all over body; Fever; Chills; Myalgia; Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia) and HEADACHE (Headache) in a 39-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia), HEADACHE (Headache) and NAUSEA (Nausea). At the time of the report, SENSITIVE SKIN (Skin sensitivity all over body), PYREXIA (Fever), CHILLS (Chills), MYALGIA (Myalgia), HEADACHE (Headache) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Patient took acetaminophen and ibuprofen for treatment.
Sex: M
Vaccine: COVID19
Symptoms: Arthralgia, Vaccination site pain
Clinical narrative: left shoulder was aching all night; left shoulder was throbbing all night; This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Jan-2021 at 8:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Jan-2021, the patient experienced ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night). At the time of the report, ARTHRALGIA (left shoulder was aching all night) and VACCINATION SITE PAIN (left shoulder was throbbing all night) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling hot, Heart rate increased, Mobility decreased, Musculoskeletal discomfort
Clinical narrative: nerve pain; increased heart rate; dizzy, drunk like feeling; a feeling of heaviness in her body; feeling hot with no fever; having trouble standing; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body) and FEELING HOT (feeling hot with no fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included ATENOLOL and SIMVASTATIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body), FEELING HOT (feeling hot with no fever), MOBILITY DECREASED (having trouble standing) and VACCINATION SITE PAIN (injection site pain). At the time of the report, NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body), FEELING HOT (feeling hot with no fever), MOBILITY DECREASED (having trouble standing) and VACCINATION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Neuralgia, Vaccination site pain
Clinical narrative: nerve pain; increased heart rate; dizzy, drunk like feeling; a feeling of heaviness in her body; feeling hot with no fever; having trouble standing; injection site pain; This spontaneous case was reported by a consumer and describes the occurrence of NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body) and FEELING HOT (feeling hot with no fever) in a 75-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No relevant medical history was reported.  Concomitant products included ATENOLOL and SIMVASTATIN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body), FEELING HOT (feeling hot with no fever), MOBILITY DECREASED (having trouble standing) and VACCINATION SITE PAIN (injection site pain). At the time of the report, NEURALGIA (nerve pain), HEART RATE INCREASED (increased heart rate), DIZZINESS (dizzy, drunk like feeling), MUSCULOSKELETAL DISCOMFORT (a feeling of heaviness in her body), FEELING HOT (feeling hot with no fever), MOBILITY DECREASED (having trouble standing) and VACCINATION SITE PAIN (injection site pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: their arm was sored; slight headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (their arm was sored) and HEADACHE (slight headache) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (their arm was sored) and HEADACHE (slight headache). At the time of the report, PAIN IN EXTREMITY (their arm was sored) and HEADACHE (slight headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.   No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itchy; injection site was became red; Injection site was became swollen; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (injection site was became red) and VACCINATION SITE SWELLING (Injection site was became swollen) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concomitant products included ROSUVASTATIN and VITAMINS NOS for an unknown indication.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Itchy), VACCINATION SITE ERYTHEMA (injection site was became red) and VACCINATION SITE SWELLING (Injection site was became swollen). On 21-Jan-2021, VACCINATION SITE PRURITUS (Itchy) had resolved. On 24-Jan-2021, VACCINATION SITE SWELLING (Injection site was became swollen) was resolving. At the time of the report, VACCINATION SITE ERYTHEMA (injection site was became red) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       patient used hot compress and took ibuprofen for treatment   Most recent FOLLOW-UP information incorporated above includes: On 23-Jan-2021: No specific follow-up information recorded.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Body temperature, Chills, Malaise, Pyrexia
Clinical narrative: Chills; So sick that could not get out of bed; High fever over 102 F; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (So sick that could not get out of bed), PYREXIA (High fever over 102 F) and CHILLS (Chills) in an 84-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041L20A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 (They got the COVID and quarantine for 4 weeks.).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced MALAISE (So sick that could not get out of bed) and PYREXIA (High fever over 102 F). On an unknown date, the patient experienced CHILLS (Chills). On 18-Jan-2021, MALAISE (So sick that could not get out of bed) outcome was unknown. At the time of the report, PYREXIA (High fever over 102 F) and CHILLS (Chills) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 16-Jan-2021, Body temperature: 102 (High) fever over 102 degree Fahrenheit.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.   Patient has severe spine problem and takes medications for that. Patient took ibuprofen for treatment of adverse events.
Age: 50.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Injection site itching, went away but developed again on 22Jan2021; injection site redness, went away but developed again on 22Jan2021; This spontaneous case was reported by a dentist and describes the occurrence of VACCINATION SITE PRURITUS (Injection site itching, went away but developed again on 22Jan2021) and VACCINATION SITE ERYTHEMA (injection site redness, went away but developed again on 22Jan2021) in a 50-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (Injection site itching, went away but developed again on 22Jan2021) and VACCINATION SITE ERYTHEMA (injection site redness, went away but developed again on 22Jan2021). At the time of the report, VACCINATION SITE PRURITUS (Injection site itching, went away but developed again on 22Jan2021) and VACCINATION SITE ERYTHEMA (injection site redness, went away but developed again on 22Jan2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported. No treatment medications were reported.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Nausea, Pyrexia
Clinical narrative: Bad headache; Nausea; Exhaustion; Low grade fever; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Bad headache), NAUSEA (Nausea), FATIGUE (Exhaustion) and PYREXIA (Low grade fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L2A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced HEADACHE (Bad headache), NAUSEA (Nausea), FATIGUE (Exhaustion) and PYREXIA (Low grade fever). On 22-Jan-2021, NAUSEA (Nausea) had resolved. At the time of the report, HEADACHE (Bad headache), FATIGUE (Exhaustion) and PYREXIA (Low grade fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Swelling, Vaccination site swelling
Clinical narrative: swollen up between the neck and chin; on the site of the shot it was swollen up a little bit; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swollen up between the neck and chin) and VACCINATION SITE SWELLING (on the site of the shot it was swollen up a little bit) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced VACCINATION SITE SWELLING (on the site of the shot it was swollen up a little bit). On 24-Jan-2021, the patient experienced SWELLING (swollen up between the neck and chin). At the time of the report, SWELLING (swollen up between the neck and chin) and VACCINATION SITE SWELLING (on the site of the shot it was swollen up a little bit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       relevant concomitant medications were reported.   No treatment medications were reported.
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site swelling
Clinical narrative: Swelling at injection site; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE SWELLING (Swelling at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INJECTION SITE SWELLING (Swelling at injection site). At the time of the report, INJECTION SITE SWELLING (Swelling at injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.  In A telephone contact made on 14Apr2021, patient reported her events have resolved and she doesn't wish to be further contacted.
Age: 78.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Sensation of foreign body
Clinical narrative: Not getting enough air; Felt like something stuck in her throat; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Not getting enough air) and SENSATION OF FOREIGN BODY (Felt like something stuck in her throat) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced DYSPNOEA (Not getting enough air) and SENSATION OF FOREIGN BODY (Felt like something stuck in her throat). At the time of the report, DYSPNOEA (Not getting enough air) and SENSATION OF FOREIGN BODY (Felt like something stuck in her throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.        No relevant concomitant medications were reported.   No treatment information was provided.
Sex: M
Vaccine: COVID19
Symptoms: Rash pruritic
Clinical narrative: Itching and hives; This spontaneous case was reported by a consumer and describes the occurrence of RASH PRURITIC (Itching and hives) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Jan-2021, the patient experienced RASH PRURITIC (Itching and hives). At the time of the report, RASH PRURITIC (Itching and hives) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported Patient was given diphenhydramine for treatment and his symptoms were relieved after that as per reporter.
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lip swelling, Nausea, Swollen tongue
Clinical narrative: extreme nausea; headache; lip swollen; tongue swollen; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (lip swollen), SWOLLEN TONGUE (tongue swollen), NAUSEA (extreme nausea) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 21-Jan-2021 at 9:00 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced LIP SWELLING (lip swollen) and SWOLLEN TONGUE (tongue swollen). On 21-Jan-2021 at 12:00 PM, the patient experienced NAUSEA (extreme nausea) and HEADACHE (headache). At the time of the report, LIP SWELLING (lip swollen), SWOLLEN TONGUE (tongue swollen), NAUSEA (extreme nausea) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.    No treatment information was provided.
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Injected limb mobility decreased, Pain in extremity, Peripheral swelling
Clinical narrative: Arm is swollen; Red hot going down the arm and spreading; Red hot going down the arm; Arm sore; The swelling limits its (arm) use; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Red hot going down the arm and spreading), FEELING HOT (Red hot going down the arm), PAIN IN EXTREMITY (Arm sore) and INJECTED LIMB MOBILITY DECREASED (The swelling limits its (arm) use) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Red hot going down the arm and spreading), FEELING HOT (Red hot going down the arm), PAIN IN EXTREMITY (Arm sore) and INJECTED LIMB MOBILITY DECREASED (The swelling limits its (arm) use). At the time of the report, PERIPHERAL SWELLING (Arm is swollen), ERYTHEMA (Red hot going down the arm and spreading), FEELING HOT (Red hot going down the arm), PAIN IN EXTREMITY (Arm sore) and INJECTED LIMB MOBILITY DECREASED (The swelling limits its (arm) use) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported No treatment medications were reported
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain, Pyrexia
Clinical narrative: body pain; fever at 101 deg F; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (body pain) and PYREXIA (fever at 101 deg F) in a 27-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Jan-2021, the patient experienced PAIN (body pain) and PYREXIA (fever at 101 deg F). At the time of the report, PAIN (body pain) and PYREXIA (fever at 101 deg F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 22-Jan-2021, Body temperature: 101 (High) degree at 11pm.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported patient took acetaminophen for treatment
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Feeling abnormal, Pyrexia, Sputum discoloured
Clinical narrative: Shortness of breath; Coughing up bright colored phlegm; Feels terrible; Fever; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Shortness of breath), SPUTUM DISCOLOURED (Coughing up bright colored phlegm), FEELING ABNORMAL (Feels terrible) and PYREXIA (Fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Jan-2021, the patient experienced DYSPNOEA (Shortness of breath), SPUTUM DISCOLOURED (Coughing up bright colored phlegm), FEELING ABNORMAL (Feels terrible) and PYREXIA (Fever). At the time of the report, DYSPNOEA (Shortness of breath), SPUTUM DISCOLOURED (Coughing up bright colored phlegm), FEELING ABNORMAL (Feels terrible) and PYREXIA (Fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No relevant concomitant medications were reported.   No treatment information was provided.
Age: 66.0
Sex: M
Vaccine: COVID19
Symptoms: Cough, Oropharyngeal pain, Pain in extremity
Clinical narrative: Non-productive cough; sore throat; Sore arm; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (Sore arm), OROPHARYNGEAL PAIN (sore throat) and COUGH (Non-productive cough) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 037K20A) for COVID-19 vaccination.     Concurrent medical conditions included COVID-19 (Tested positive for COVID-19) on 03-Jan-2021.    On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Dec-2020, the patient experienced PAIN IN EXTREMITY (Sore arm). On 01-Jan-2021, the patient experienced OROPHARYNGEAL PAIN (sore throat). On 03-Jan-2021, the patient experienced COUGH (Non-productive cough). At the time of the report, PAIN IN EXTREMITY (Sore arm) had resolved and OROPHARYNGEAL PAIN (sore throat) and COUGH (Non-productive cough) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications were reported.  No treatment information was provided.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Injection site erythema, Injection site pain, Nausea, Vaccination site urticaria
Clinical narrative: red area has returned; nausea; fatigue; pain for about 3 days after the injection; site reaction witha red welt; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE URTICARIA (site reaction witha red welt), INJECTION SITE ERYTHEMA (red area has returned), INJECTION SITE PAIN (pain for about 3 days after the injection), NAUSEA (nausea) and FATIGUE (fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jan-2021, the patient experienced VACCINATION SITE URTICARIA (site reaction witha red welt) and INJECTION SITE PAIN (pain for about 3 days after the injection). On 22-Jan-2021, the patient experienced INJECTION SITE ERYTHEMA (red area has returned), NAUSEA (nausea) and FATIGUE (fatigue). On 17-Jan-2021, VACCINATION SITE URTICARIA (site reaction witha red welt) had resolved. At the time of the report, INJECTION SITE ERYTHEMA (red area has returned) had not resolved, INJECTION SITE PAIN (pain for about 3 days after the injection) had resolved and NAUSEA (nausea) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.  No treatment information was reported.    This case was linked to MOD-2021-145527 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Apr-2021: Follow-up was received on 14-apr-2021 and provided patient  Email address and information about 2nd dose of vaccination. On 19-May-2021: follow-up was received on 19-may-2021 information included Patient's medical history ,concomitant medication and added new events after the 2 nd dose of vaccination.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pain in extremity
Clinical narrative: Dizziness; Sore arm; Nausea; This spontaneous case was reported by a patient and describes the occurrence of DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 042620A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea). At the time of the report, DIZZINESS (Dizziness), PAIN IN EXTREMITY (Sore arm) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Diarrhoea, Dizziness, Sneezing
Clinical narrative: Dizziness; Sneezing; Diarrhea; Chills; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (Dizziness), SNEEZING (Sneezing), DIARRHOEA (Diarrhea) and CHILLS (Chills) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced DIZZINESS (Dizziness), SNEEZING (Sneezing), DIARRHOEA (Diarrhea) and CHILLS (Chills). At the time of the report, DIZZINESS (Dizziness), SNEEZING (Sneezing), DIARRHOEA (Diarrhea) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications are were reported.  Patient reported her temperature to be around 96.9 Patient had not used any medications for treatment at the time of report.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Injection site erythema, Malaise, Nausea
Clinical narrative: diarrhea; abdominal pain; felt lousy; rash; sore arm; redness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash) and VACCINATION SITE PAIN (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, QUINAPRIL and PRAVASTATIN.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea) outcome was unknown.            Patient used Tylenol and Pepto-Bismol for treatment of symptoms.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain, Vaccination site rash
Clinical narrative: diarrhea; abdominal pain; felt lousy; rash; sore arm; redness; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash) and VACCINATION SITE PAIN (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028L20A and 011J20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No medical history reported.). Concomitant products included LEVOTHYROXINE, QUINAPRIL and PRAVASTATIN.   On 22-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 19-Jan-2021, the patient experienced DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea). At the time of the report, DIARRHOEA (diarrhea), ABDOMINAL PAIN (abdominal pain), MALAISE (felt lousy), VACCINATION SITE RASH (rash), VACCINATION SITE PAIN (sore arm), INJECTION SITE ERYTHEMA (redness) and NAUSEA (nausea) outcome was unknown.            Patient used Tylenol and Pepto-Bismol for treatment of symptoms.
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site pruritus, Vaccination site rash, Vaccination site swelling
Clinical narrative: itchy spot around injection site; large red rash; Size of apple or tennis ball swollen; Red rash; sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (itchy spot around injection site), VACCINATION SITE RASH (large red rash), VACCINATION SITE SWELLING (Size of apple or tennis ball swollen) and VACCINATION SITE ERYTHEMA (Red rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced PAIN IN EXTREMITY (sore arm). On 21-Jan-2021, the patient experienced VACCINATION SITE PRURITUS (itchy spot around injection site), VACCINATION SITE RASH (large red rash), VACCINATION SITE SWELLING (Size of apple or tennis ball swollen) and VACCINATION SITE ERYTHEMA (Red rash). At the time of the report, PAIN IN EXTREMITY (sore arm), VACCINATION SITE PRURITUS (itchy spot around injection site), VACCINATION SITE RASH (large red rash), VACCINATION SITE SWELLING (Size of apple or tennis ball swollen) and VACCINATION SITE ERYTHEMA (Red rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Exposure during pregnancy, Pregnancy test, Ultrasound foetal
Clinical narrative: Pregnant; This spontaneous prospective pregnancy case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of EXPOSURE DURING PREGNANCY (Pregnant) in a 36-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Pregnancy (Live,full term birth) on 17-Apr-2015. Concomitant products included MINERALS NOS, VITAMINS NOS (PRENATAL VITAMINS [MINERALS NOS;VITAMINS NOS]) from 14-Jan-2020 to an unknown date, ACETYLSALICYLIC ACID (BABY ASPIRIN) from 14-Jan-2020 to an unknown date, FOLIC ACID from 14-Jan-2021 to an unknown date, ASCORBIC ACID, CALCIUM, COLECALCIFEROL, MAGNESIUM (CAL-C-MAG WITH VIT D) from 14-Jan-2020 to an unknown date and SERTRALINE HYDROCHLORIDE (ZOLOFT) from 14-Feb-2021 to an unknown date for an unknown indication.    On 08-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was on 31-May-2020 and the estimated date of delivery was 07-Mar-2021. On 08-Feb-2021, the patient experienced EXPOSURE DURING PREGNANCY (Pregnant). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) beginning around the  thirty-sixth week of the pregnancy.  On 08-Feb-2021, EXPOSURE DURING PREGNANCY (Pregnant) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 25-Jun-2020, Pregnancy test: positive positive (Positive) positive. In 2021, Ultrasound foetal: inconclusive (Inconclusive) Inconclusive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No treatment medication details was reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Feb-2021: Internal review on 27-JUL-2021 resulted in update of Lab data, medical history, Number of fetus, Gravida, para, Birth type and fetal outcome. On 23-Feb-2021: significant additional information updated.
Age: 94.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus, Vaccination site rash
Clinical narrative: Rash on the injection site; redness; Itchiness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 20-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) in a 94-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20A) for COVID-19 vaccination.     No medical history information was reported.     On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Jan-2021, the patient experienced VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness). At the time of the report, VACCINATION SITE RASH (Rash on the injection site), VACCINATION SITE ERYTHEMA (redness) and VACCINATION SITE PRURITUS (Itchiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Coordination abnormal, Dizziness
Clinical narrative: Dizzy; uncoordinated; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Dizzy) and COORDINATION ABNORMAL (uncoordinated) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J2OA) for COVID-19 vaccination.     Concurrent medical conditions included Leukemia. Concomitant products included METFORMIN, HYDROXYUREA, IRON and ALOGLIPTIN for an unknown indication.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced DIZZINESS (Dizzy) and COORDINATION ABNORMAL (uncoordinated). At the time of the report, DIZZINESS (Dizzy) and COORDINATION ABNORMAL (uncoordinated) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment details were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Follow up received and contains No new information
Sex: F
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: pretty red spot the half the size of a silver dollar that got bigger; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger). On 22-Jan-2021, ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 23-Jan-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) in an elderly female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     NO medical history information was reported.     On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Jan-2021, the patient experienced ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger). On 22-Jan-2021, ERYTHEMA (pretty red spot the half the size of a silver dollar that got bigger) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
Sex: F
Vaccine: COVID19
Symptoms: Fear, Vaccination site erythema, Vaccination site rash
Clinical narrative: very red; very frightened; rash at injection site about 2 inches long; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at injection site about 2 inches long). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened). At the time of the report, VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 27-Jan-2021 and was forwarded to Moderna on 01-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No reported medical history).    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Jan-2021, the patient experienced VACCINATION SITE RASH (rash at injection site about 2 inches long). On 27-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened). At the time of the report, VACCINATION SITE RASH (rash at injection site about 2 inches long), VACCINATION SITE ERYTHEMA (very red) and FEAR (very frightened) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided.  No treatment details were reported.
Sex: M
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: tested positive for COVID 19; This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID 19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced COVID-19 (tested positive for COVID 19). At the time of the report, COVID-19 (tested positive for COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment for the events was not reported. This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 22-Jan-2021 and was forwarded to Moderna on 24-Jan-2021.    This spontaneous case was reported by an other health care professional (subsequently medically confirmed) and describes the occurrence of COVID-19 (tested positive for COVID 19) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History Information was Reported.     On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jan-2021, the patient experienced COVID-19 (tested positive for COVID 19). At the time of the report, COVID-19 (tested positive for COVID 19) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Treatment for the events was not reported.